Page last updated: 2024-08-23

etoposide and gdc 0449

etoposide has been researched along with gdc 0449 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belani, CP; Chen, HX; Dahlberg, SE; Fleisher, M; Hann, CL; Monga, M; Ramalingam, SS; Rudin, CM; Schiller, JH; Shanks, JC; Sturtz, K; Takebe, N; Tester, WJ; Velasco, MR	1

Trials

1 trial(s) available for etoposide and gdc 0449

Article	Year
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508). Cancer, 2016, Aug-01, Volume: 122, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Pyridines; Small Cell Lung Carcinoma; Treatment Outcome	2016

Article

Year

Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508).

Cancer, 2016, Aug-01, Volume: 122, Issue:15

Topics: Adult; Aged; Aged, 80 and over; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Pyridines; Small Cell Lung Carcinoma; Treatment Outcome

2016